| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 1.40e-12 | 5 | 87 | 5 | GO:0052871 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 2.91e-11 | 7 | 87 | 5 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 2.91e-11 | 7 | 87 | 5 | GO:0018685 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 3.46e-10 | 10 | 87 | 5 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 3.46e-10 | 10 | 87 | 5 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 3.46e-10 | 10 | 87 | 5 | GO:0102033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 1.75e-09 | 13 | 87 | 5 | GO:0016713 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 5.57e-08 | 24 | 87 | 5 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.05e-07 | 27 | 87 | 5 | GO:0008391 | |
| GeneOntologyMolecularFunction | aromatase activity | 4.09e-07 | 35 | 87 | 5 | GO:0070330 | |
| GeneOntologyMolecularFunction | arachidonate binding | 4.42e-07 | 15 | 87 | 4 | GO:0050544 | |
| GeneOntologyMolecularFunction | icosanoid binding | 5.88e-07 | 16 | 87 | 4 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 5.88e-07 | 16 | 87 | 4 | GO:0050543 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 8.16e-07 | 40 | 87 | 5 | GO:0016709 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 2.29e-06 | 49 | 87 | 5 | GO:0016712 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 6.35e-06 | 28 | 87 | 4 | GO:0036041 | |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 1.88e-05 | 2 | 87 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 1.88e-05 | 2 | 87 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 5.61e-05 | 3 | 87 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.47e-04 | 115 | 87 | 5 | GO:0004497 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 1.86e-04 | 5 | 87 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | fatty acid binding | 2.34e-04 | 69 | 87 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | heme binding | 5.68e-04 | 154 | 87 | 5 | GO:0020037 | |
| GeneOntologyMolecularFunction | transition metal ion binding | TTF2 CYP4F8 TRIM67 P2RX2 TRIM9 ZNF75D MARCHF7 ZNF407 PHF14 CYP4F2 CYP4F3 CYP4F12 ARIH1 CYP4F11 | 5.95e-04 | 1189 | 87 | 14 | GO:0046914 |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 7.55e-04 | 164 | 87 | 5 | GO:0046906 | |
| GeneOntologyMolecularFunction | iron ion binding | 7.97e-04 | 166 | 87 | 5 | GO:0005506 | |
| GeneOntologyMolecularFunction | organic acid binding | 8.53e-04 | 254 | 87 | 6 | GO:0043177 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.23e-03 | 107 | 87 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1.60e-03 | 194 | 87 | 5 | GO:0016705 | |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 1.90e-03 | 15 | 87 | 2 | GO:0051011 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.74e-03 | 18 | 87 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | actin filament binding | 3.15e-03 | 227 | 87 | 5 | GO:0051015 | |
| GeneOntologyMolecularFunction | histone modifying activity | 3.27e-03 | 229 | 87 | 5 | GO:0140993 | |
| GeneOntologyMolecularFunction | cadherin binding | 3.65e-03 | 339 | 87 | 6 | GO:0045296 | |
| GeneOntologyMolecularFunction | lipid binding | PLA2G7 CYP4F8 P2RX2 SPTBN1 SPTBN2 CYP4F2 CYP4F12 ARHGAP35 CYP4F11 CLVS1 S1PR3 | 3.69e-03 | 988 | 87 | 11 | GO:0008289 |
| GeneOntologyMolecularFunction | carboxylic acid binding | 3.93e-03 | 239 | 87 | 5 | GO:0031406 | |
| GeneOntologyMolecularFunction | structural molecule activity | KRT23 MRPL4 DLGAP1 MFAP4 COL9A1 SPTBN1 SPTBN2 COPB2 MACF1 TUBGCP4 | 5.32e-03 | 891 | 87 | 10 | GO:0005198 |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 7.11e-12 | 6 | 87 | 5 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 2.48e-11 | 7 | 87 | 5 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 6.59e-11 | 8 | 87 | 5 | GO:0036100 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 5.38e-10 | 11 | 87 | 5 | GO:1901523 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 9.20e-10 | 12 | 87 | 5 | GO:0042758 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 2.96e-08 | 22 | 87 | 5 | GO:1901569 | |
| GeneOntologyBiologicalProcess | menaquinone catabolic process | 7.25e-08 | 3 | 87 | 3 | GO:0042361 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 2.86e-07 | 14 | 87 | 4 | GO:0097267 | |
| GeneOntologyBiologicalProcess | menaquinone metabolic process | 2.89e-07 | 4 | 87 | 3 | GO:0009233 | |
| GeneOntologyBiologicalProcess | phylloquinone metabolic process | 2.89e-07 | 4 | 87 | 3 | GO:0042374 | |
| GeneOntologyBiologicalProcess | phylloquinone catabolic process | 2.89e-07 | 4 | 87 | 3 | GO:0042376 | |
| GeneOntologyBiologicalProcess | vitamin K catabolic process | 2.89e-07 | 4 | 87 | 3 | GO:0042377 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 6.42e-07 | 73 | 87 | 6 | GO:1901616 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 7.90e-07 | 41 | 87 | 5 | GO:0006691 | |
| GeneOntologyBiologicalProcess | prostaglandin catabolic process | 1.44e-06 | 6 | 87 | 3 | GO:1905344 | |
| GeneOntologyBiologicalProcess | prostanoid catabolic process | 1.44e-06 | 6 | 87 | 3 | GO:0062232 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 1.01e-05 | 68 | 87 | 5 | GO:0019369 | |
| GeneOntologyBiologicalProcess | vitamin K metabolic process | 1.17e-05 | 11 | 87 | 3 | GO:0042373 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin catabolic process | 1.55e-05 | 12 | 87 | 3 | GO:0042363 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 2.51e-05 | 82 | 87 | 5 | GO:1901568 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 3.35e-05 | 382 | 87 | 9 | GO:0016042 | |
| GeneOntologyBiologicalProcess | vitamin catabolic process | 5.65e-05 | 18 | 87 | 3 | GO:0009111 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin metabolic process | 6.34e-05 | 51 | 87 | 4 | GO:0006775 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 9.12e-05 | 21 | 87 | 3 | GO:0042182 | |
| GeneOntologyBiologicalProcess | fatty acid catabolic process | 1.32e-04 | 116 | 87 | 5 | GO:0009062 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 1.80e-04 | 124 | 87 | 5 | GO:0001676 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 2.09e-04 | 128 | 87 | 5 | GO:0033559 | |
| GeneOntologyBiologicalProcess | vitamin E metabolic process | 2.61e-04 | 6 | 87 | 2 | GO:0042360 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 3.38e-04 | 142 | 87 | 5 | GO:0006690 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid catabolic process | 3.73e-04 | 145 | 87 | 5 | GO:0072329 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level chemical homeostasis | 5.72e-04 | 90 | 87 | 4 | GO:0140962 | |
| GeneOntologyBiologicalProcess | cilium assembly | 5.73e-04 | 444 | 87 | 8 | GO:0060271 | |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | 7.32e-04 | 461 | 87 | 8 | GO:0006631 | |
| GeneOntologyCellularComponent | lamellar body membrane | 1.02e-04 | 4 | 87 | 2 | GO:0097232 | |
| GeneOntologyCellularComponent | intraciliary transport particle | 2.12e-04 | 28 | 87 | 3 | GO:0030990 | |
| GeneOntologyCellularComponent | shelterin complex | 3.55e-04 | 7 | 87 | 2 | GO:0070187 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 6.05e-04 | 9 | 87 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | spectrin | 6.05e-04 | 9 | 87 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | motile cilium | 7.01e-04 | 355 | 87 | 7 | GO:0031514 | |
| GeneOntologyCellularComponent | sperm principal piece | 8.15e-04 | 44 | 87 | 3 | GO:0097228 | |
| GeneOntologyCellularComponent | chromosome, telomeric region | 8.46e-04 | 176 | 87 | 5 | GO:0000781 | |
| GeneOntologyCellularComponent | ciliary tip | 1.05e-03 | 48 | 87 | 3 | GO:0097542 | |
| GeneOntologyCellularComponent | cilium | DNHD1 SLC9C1 IFT172 IFT81 DNAH17 WDR35 TAS2R20 ARHGAP35 LYAR CATSPERG CNGA4 | 1.23e-03 | 898 | 87 | 11 | GO:0005929 |
| GeneOntologyCellularComponent | nuclear telomere cap complex | 1.30e-03 | 13 | 87 | 2 | GO:0000783 | |
| GeneOntologyCellularComponent | telomere cap complex | 1.30e-03 | 13 | 87 | 2 | GO:0000782 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 1.32e-03 | 114 | 87 | 4 | GO:0005798 | |
| GeneOntologyCellularComponent | chromosome, telomeric repeat region | 1.51e-03 | 14 | 87 | 2 | GO:0140445 | |
| GeneOntologyCellularComponent | sperm flagellum | 2.01e-03 | 214 | 87 | 5 | GO:0036126 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 2.11e-03 | 61 | 87 | 3 | GO:0030660 | |
| HumanPheno | Aplasia of the 1st metacarpal | 1.36e-05 | 8 | 33 | 3 | HP:0010035 | |
| HumanPheno | Partial absence of thumb | 2.03e-05 | 9 | 33 | 3 | HP:0009659 | |
| HumanPheno | Aplasia of the proximal phalanges of the hand | 2.03e-05 | 9 | 33 | 3 | HP:0010242 | |
| HumanPheno | Jerky ocular pursuit movements | 2.03e-05 | 9 | 33 | 3 | HP:0008003 | |
| HumanPheno | Aplasia/Hypoplasia of the uvula | 2.68e-05 | 28 | 33 | 4 | HP:0010293 | |
| HumanPheno | Aplasia of metacarpal bones | 5.24e-05 | 12 | 33 | 3 | HP:0010048 | |
| HumanPheno | Short uvula | 1.22e-04 | 3 | 33 | 2 | HP:0010812 | |
| HumanPheno | Aplasia involving bones of the upper limbs | 1.31e-04 | 16 | 33 | 3 | HP:0009823 | |
| HumanPheno | Aplasia of the phalanges of the hand | 1.31e-04 | 16 | 33 | 3 | HP:0009802 | |
| HumanPheno | Hypoplasia of the radius | 1.51e-04 | 43 | 33 | 4 | HP:0002984 | |
| HumanPheno | Aplasia/Hypoplasia of the radius | 1.59e-04 | 82 | 33 | 5 | HP:0006501 | |
| HumanPheno | Aplasia/Hypoplasia of the ribs | 2.32e-04 | 140 | 33 | 6 | HP:0006712 | |
| MousePheno | abnormal retina blood vessel morphology | CYP4F8 ZNF716 IFT172 IFT81 CYP4F2 CYP4F12 THNSL2 CYP4F11 S1PR3 | 2.67e-06 | 234 | 71 | 9 | MP:0010097 |
| MousePheno | abnormal retina vasculature morphology | CYP4F8 ZNF716 IFT172 IFT81 COPB2 CYP4F2 CYP4F12 THNSL2 CYP4F11 S1PR3 | 2.58e-05 | 390 | 71 | 10 | MP:0002792 |
| MousePheno | abnormal eye vasculature morphology | CYP4F8 ZNF716 IFT172 IFT81 COPB2 CYP4F2 CYP4F12 THNSL2 CYP4F11 S1PR3 | 4.37e-05 | 415 | 71 | 10 | MP:0031346 |
| MousePheno | abnormal pulmonary alveolar parenchyma morphology | 9.21e-05 | 90 | 71 | 5 | MP:0010901 | |
| MousePheno | abnormal lung morphology | MFAP4 LIPA ABCA3 ATR TRIM9 ABCA12 SYNE1 SPTBN1 WDR35 PHF14 XRCC2 PRDM16 S1PR3 | 1.11e-04 | 767 | 71 | 13 | MP:0001175 |
| MousePheno | enlarged mesenteric lymph nodes | 1.15e-04 | 19 | 71 | 3 | MP:0008466 | |
| MousePheno | abnormal pulmonary alveolar system morphology | 1.23e-04 | 296 | 71 | 8 | MP:0010899 | |
| MousePheno | abnormal feces composition | 1.38e-04 | 98 | 71 | 5 | MP:0003868 | |
| Domain | Spectrin | 7.05e-10 | 23 | 85 | 6 | PF00435 | |
| Domain | Spectrin_repeat | 3.24e-09 | 29 | 85 | 6 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 6.12e-09 | 32 | 85 | 6 | IPR018159 | |
| Domain | SPEC | 6.12e-09 | 32 | 85 | 6 | SM00150 | |
| Domain | Cyt_P450_E_grp-I | 1.84e-06 | 45 | 85 | 5 | IPR002401 | |
| Domain | Actinin_actin-bd_CS | 3.31e-06 | 23 | 85 | 4 | IPR001589 | |
| Domain | ACTININ_2 | 3.31e-06 | 23 | 85 | 4 | PS00020 | |
| Domain | ACTININ_1 | 3.31e-06 | 23 | 85 | 4 | PS00019 | |
| Domain | Cyt_P450_CS | 4.19e-06 | 53 | 85 | 5 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 6.03e-06 | 57 | 85 | 5 | PS00086 | |
| Domain | - | 6.57e-06 | 58 | 85 | 5 | 1.10.630.10 | |
| Domain | p450 | 6.57e-06 | 58 | 85 | 5 | PF00067 | |
| Domain | Cyt_P450 | 7.78e-06 | 60 | 85 | 5 | IPR001128 | |
| Domain | CH | 1.16e-05 | 65 | 85 | 5 | SM00033 | |
| Domain | CH | 1.66e-05 | 70 | 85 | 5 | PF00307 | |
| Domain | - | 1.78e-05 | 71 | 85 | 5 | 1.10.418.10 | |
| Domain | CH | 2.04e-05 | 73 | 85 | 5 | PS50021 | |
| Domain | CH-domain | 2.33e-05 | 75 | 85 | 5 | IPR001715 | |
| Domain | PI3/4_kinase_CS | 3.98e-05 | 15 | 85 | 3 | IPR018936 | |
| Domain | - | 4.88e-05 | 16 | 85 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 4.88e-05 | 16 | 85 | 3 | SM00146 | |
| Domain | PI3/4_kinase_cat_dom | 7.07e-05 | 18 | 85 | 3 | IPR000403 | |
| Domain | PI3_PI4_kinase | 7.07e-05 | 18 | 85 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 7.07e-05 | 18 | 85 | 3 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 7.07e-05 | 18 | 85 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 7.07e-05 | 18 | 85 | 3 | PS00916 | |
| Domain | CRAL_TRIO | 1.14e-04 | 21 | 85 | 3 | PF00650 | |
| Domain | Spectrin_bsu | 1.22e-04 | 4 | 85 | 2 | IPR016343 | |
| Domain | - | 1.51e-04 | 23 | 85 | 3 | 3.40.525.10 | |
| Domain | SEC14 | 1.95e-04 | 25 | 85 | 3 | SM00516 | |
| Domain | VWA_2 | 2.03e-04 | 5 | 85 | 2 | PF13519 | |
| Domain | FATC | 2.03e-04 | 5 | 85 | 2 | PF02260 | |
| Domain | CRAL_TRIO | 2.46e-04 | 27 | 85 | 3 | PS50191 | |
| Domain | CRAL-TRIO_dom | 2.74e-04 | 28 | 85 | 3 | IPR001251 | |
| Domain | FAT | 3.03e-04 | 6 | 85 | 2 | PS51189 | |
| Domain | FATC | 3.03e-04 | 6 | 85 | 2 | PS51190 | |
| Domain | FAT | 3.03e-04 | 6 | 85 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 3.03e-04 | 6 | 85 | 2 | IPR003151 | |
| Domain | FATC_dom | 3.03e-04 | 6 | 85 | 2 | IPR003152 | |
| Domain | PIK_FAT | 3.03e-04 | 6 | 85 | 2 | IPR014009 | |
| Domain | FATC | 3.03e-04 | 6 | 85 | 2 | SM01343 | |
| Domain | INT_SG_DDX_CT_C | 5.63e-04 | 8 | 85 | 2 | PF15300 | |
| Domain | INT_SG_DDX_CT_C | 5.63e-04 | 8 | 85 | 2 | IPR029307 | |
| Domain | PH_dom-spectrin-type | 7.22e-04 | 9 | 85 | 2 | IPR001605 | |
| Domain | ARM-type_fold | 8.96e-04 | 339 | 85 | 7 | IPR016024 | |
| Domain | COS_domain | 1.31e-03 | 12 | 85 | 2 | IPR017903 | |
| Domain | COS | 1.31e-03 | 12 | 85 | 2 | PS51262 | |
| Domain | ABC_A | 1.31e-03 | 12 | 85 | 2 | IPR026082 | |
| Domain | Bbox_C | 2.07e-03 | 15 | 85 | 2 | IPR003649 | |
| Domain | BBC | 2.07e-03 | 15 | 85 | 2 | SM00502 | |
| Domain | TPR-like_helical_dom | 4.23e-03 | 233 | 85 | 5 | IPR011990 | |
| Domain | EPHD | 4.46e-03 | 22 | 85 | 2 | PS51805 | |
| Pathway | REACTOME_EICOSANOIDS | 2.32e-09 | 12 | 72 | 5 | M27129 | |
| Pathway | REACTOME_EICOSANOIDS | 2.32e-09 | 12 | 72 | 5 | MM14845 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 5.83e-09 | 14 | 72 | 5 | MM15842 | |
| Pathway | REACTOME_FATTY_ACIDS | 8.71e-09 | 15 | 72 | 5 | M27126 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 2.46e-08 | 18 | 72 | 5 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 2.46e-08 | 18 | 72 | 5 | MM14841 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 1.48e-07 | 25 | 72 | 5 | MM14858 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 6.41e-07 | 33 | 72 | 5 | MM15918 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 6.41e-07 | 33 | 72 | 5 | MM15963 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 3.51e-06 | 21 | 72 | 4 | M27137 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.44e-05 | 61 | 72 | 5 | MM14861 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 1.56e-05 | 62 | 72 | 5 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.82e-05 | 64 | 72 | 5 | M5650 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 2.05e-05 | 11 | 72 | 3 | MM14863 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 2.12e-05 | 66 | 72 | 5 | MM14839 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 2.72e-05 | 12 | 72 | 3 | M27128 | |
| Pathway | WP_TRYPTOPHAN_METABOLISM | 1.03e-04 | 48 | 72 | 4 | MM15902 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.88e-04 | 104 | 72 | 5 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.96e-04 | 105 | 72 | 5 | MM14842 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 2.30e-04 | 59 | 72 | 4 | M27140 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 9.05e-04 | 9 | 72 | 2 | M39819 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 9.48e-04 | 38 | 72 | 3 | MM14969 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.13e-03 | 10 | 72 | 2 | MM15112 | |
| Pubmed | 5.53e-13 | 6 | 88 | 5 | 9068972 | ||
| Pubmed | 3.83e-11 | 4 | 88 | 4 | 22665481 | ||
| Pubmed | Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. | 3.83e-11 | 4 | 88 | 4 | 11185557 | |
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 3.83e-11 | 4 | 88 | 4 | 18065749 | |
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 22969154 | ||
| Pubmed | Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation. | 1.91e-10 | 5 | 88 | 4 | 21466787 | |
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 22160543 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MRPL4 INTS6 LIPA THYN1 KALRN SYNE1 SPTBN1 SPTBN2 COPB2 TNRC6B MACF1 PRKDC ARHGAP35 LYAR CATSPERG | 8.55e-08 | 1082 | 88 | 15 | 38697112 |
| Pubmed | 1.17e-07 | 46 | 88 | 5 | 25209997 | ||
| Pubmed | 1.20e-07 | 151 | 88 | 7 | 17043677 | ||
| Pubmed | 1.80e-07 | 20 | 88 | 4 | 21689717 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ORC2 TTF2 INTS6 ATR USO1 SPTBN1 COPB2 MACF1 PRKDC HUWE1 TUBGCP4 | 2.62e-07 | 582 | 88 | 11 | 20467437 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 6.04e-07 | 281 | 88 | 8 | 28706196 | |
| Pubmed | 9.83e-07 | 70 | 88 | 5 | 15128046 | ||
| Pubmed | 1.48e-06 | 76 | 88 | 5 | 22323595 | ||
| Pubmed | 1.76e-06 | 225 | 88 | 7 | 12168954 | ||
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 2.55e-06 | 11 | 88 | 3 | 17607528 | |
| Pubmed | 3.62e-06 | 251 | 88 | 7 | 27507650 | ||
| Pubmed | DLGAP1 TRIO KALRN TRIM9 IFT172 SYNE1 IFT81 SPTBN1 SPTBN2 MACF1 MCRS1 PRKDC HUWE1 TERF2IP | 4.12e-06 | 1285 | 88 | 14 | 35914814 | |
| Pubmed | 4.56e-06 | 493 | 88 | 9 | 15368895 | ||
| Pubmed | Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. | 4.81e-06 | 44 | 88 | 4 | 12745259 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 24138531 | ||
| Pubmed | Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies. | 6.33e-06 | 2 | 88 | 2 | 18662666 | |
| Pubmed | Expression and physiological function of CYP4F subfamily in human eosinophils. | 6.33e-06 | 2 | 88 | 2 | 17980168 | |
| Pubmed | Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. | 6.33e-06 | 2 | 88 | 2 | 8026587 | |
| Pubmed | DNA structure-specific priming of ATR activation by DNA-PKcs. | 6.33e-06 | 2 | 88 | 2 | 23897887 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 18434597 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 16112640 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 15364545 | ||
| Pubmed | Caspase-3/7-mediated Cleavage of β2-spectrin is Required for Acetaminophen-induced Liver Damage. | 6.33e-06 | 2 | 88 | 2 | 26884715 | |
| Pubmed | Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP. | 6.33e-06 | 2 | 88 | 2 | 26858404 | |
| Pubmed | USP7 controls NGN3 stability and pancreatic endocrine lineage development. | 1.46e-05 | 58 | 88 | 4 | 37117185 | |
| Pubmed | Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. | 1.90e-05 | 3 | 88 | 2 | 9766667 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 31801062 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 18451257 | ||
| Pubmed | Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. | 1.90e-05 | 3 | 88 | 2 | 15145985 | |
| Pubmed | DNA Damage Signaling Is Required for Replication of Human Bocavirus 1 DNA in Dividing HEK293 Cells. | 1.90e-05 | 3 | 88 | 2 | 27733644 | |
| Pubmed | Distinct roles of ATR and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells. | 1.90e-05 | 3 | 88 | 2 | 19444312 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 26365377 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 31601897 | ||
| Pubmed | HUWE1-dependent DNA-PKcs neddylation modulates its autophosphorylation in DNA damage response. | 1.90e-05 | 3 | 88 | 2 | 32457294 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 31164689 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 2.00e-05 | 218 | 88 | 6 | 33378226 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.82e-05 | 475 | 88 | 8 | 31040226 | |
| Pubmed | DLGAP1 TRIM67 TRIO KALRN SYNE1 PI4KA SPTBN1 SPTBN2 TNRC6B MACF1 HUWE1 | 3.18e-05 | 963 | 88 | 11 | 28671696 | |
| Pubmed | 3.32e-05 | 486 | 88 | 8 | 20936779 | ||
| Pubmed | 3.45e-05 | 72 | 88 | 4 | 36376293 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 21281786 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 15998665 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 21412925 | ||
| Pubmed | A pair of E3 ubiquitin ligases compete to regulate filopodial dynamics and axon guidance. | 3.79e-05 | 4 | 88 | 2 | 31820781 | |
| Pubmed | Loss of β2-spectrin prevents cardiomyocyte differentiation and heart development. | 3.79e-05 | 4 | 88 | 2 | 24064296 | |
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 29309644 | ||
| Pubmed | 4.50e-05 | 77 | 88 | 4 | 19505873 | ||
| Pubmed | DLGAP1 GTF2E2 TRIO KALRN USO1 TRIM9 SYNE1 PI4KA SPTBN1 SPTBN2 COPB2 MACF1 ARHGAP35 | 6.23e-05 | 1431 | 88 | 13 | 37142655 | |
| Pubmed | Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. | 6.30e-05 | 5 | 88 | 2 | 19596237 | |
| Pubmed | Assembly of high order G alpha q-effector complexes with RGS proteins. | 6.30e-05 | 5 | 88 | 2 | 18936096 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 16540648 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 26784546 | ||
| Pubmed | ABC gene expression profiles have clinical importance and possibly form a new hallmark of cancer. | 6.30e-05 | 5 | 88 | 2 | 28468577 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 18577768 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 29976923 | ||
| Pubmed | 9.43e-05 | 6 | 88 | 2 | 10951572 | ||
| Pubmed | The complexity of p53 modulation: emerging patterns from divergent signals. | 9.43e-05 | 6 | 88 | 2 | 9765199 | |
| Pubmed | ST3GAL1 and βII-spectrin pathways control CAR T cell migration to target tumors. | 9.43e-05 | 6 | 88 | 2 | 37069398 | |
| Pubmed | Mammalian TRIM67 Functions in Brain Development and Behavior. | 9.43e-05 | 6 | 88 | 2 | 29911180 | |
| Pubmed | Kinetic properties of p53 phosphorylation by the human vaccinia-related kinase 1. | 9.43e-05 | 6 | 88 | 2 | 11883897 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.04e-04 | 736 | 88 | 9 | 29676528 | |
| Pubmed | Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint. | 1.32e-04 | 7 | 88 | 2 | 20818375 | |
| Pubmed | Telomere protection by TPP1/POT1 requires tethering to TIN2. | 1.32e-04 | 7 | 88 | 2 | 22099311 | |
| Pubmed | 1.32e-04 | 7 | 88 | 2 | 22337885 | ||
| Pubmed | 1.32e-04 | 7 | 88 | 2 | 17171639 | ||
| Pubmed | 1.32e-04 | 7 | 88 | 2 | 17312020 | ||
| Pubmed | Human UPF1 interacts with TPP1 and telomerase and sustains telomere leading-strand replication. | 1.32e-04 | 7 | 88 | 2 | 21829167 | |
| Pubmed | 1.32e-04 | 7 | 88 | 2 | 10673501 | ||
| Pubmed | 1.35e-04 | 102 | 88 | 4 | 11214970 | ||
| Pubmed | 1.35e-04 | 193 | 88 | 5 | 19343046 | ||
| Pubmed | DLGAP1 TRIO KALRN TRIM9 PI4KA SPTBN1 COPB2 TNRC6B MACF1 HUWE1 ARHGAP35 | 1.42e-04 | 1139 | 88 | 11 | 36417873 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.67e-04 | 202 | 88 | 5 | 33005030 | |
| Pubmed | 1.75e-04 | 8 | 88 | 2 | 15456891 | ||
| Pubmed | Vpr-binding protein antagonizes p53-mediated transcription via direct interaction with H3 tail. | 1.75e-04 | 8 | 88 | 2 | 22184063 | |
| Pubmed | 1.75e-04 | 8 | 88 | 2 | 24293640 | ||
| Pubmed | 1.75e-04 | 8 | 88 | 2 | 20810650 | ||
| Pubmed | 1.95e-04 | 209 | 88 | 5 | 36779422 | ||
| Pubmed | 2.03e-04 | 332 | 88 | 6 | 37433992 | ||
| Pubmed | 2.25e-04 | 9 | 88 | 2 | 10747897 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MRPL4 DNHD1 ATR TRIO USO1 SYNE1 PI4KA SPTBN1 COPB2 PRKDC HUWE1 LYAR | 2.47e-04 | 1425 | 88 | 12 | 30948266 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 2.51e-04 | 120 | 88 | 4 | 31413325 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 2.81e-04 | 10 | 88 | 2 | 22159418 | |
| Pubmed | Tel2 regulates the stability of PI3K-related protein kinases. | 2.81e-04 | 10 | 88 | 2 | 18160036 | |
| Pubmed | 2.81e-04 | 10 | 88 | 2 | 15983387 | ||
| Pubmed | 2.81e-04 | 10 | 88 | 2 | 17478428 | ||
| Pubmed | EHMT1 controls brown adipose cell fate and thermogenesis through the PRDM16 complex. | 2.81e-04 | 10 | 88 | 2 | 24196706 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 3.35e-04 | 235 | 88 | 5 | 28378594 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 3.43e-04 | 11 | 88 | 2 | 20427287 | |
| Pubmed | Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. | 3.43e-04 | 11 | 88 | 2 | 15758953 | |
| Pubmed | 3.43e-04 | 11 | 88 | 2 | 11709713 | ||
| Pubmed | Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors. | 3.43e-04 | 11 | 88 | 2 | 39256359 | |
| Pubmed | 3.43e-04 | 11 | 88 | 2 | 11551930 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 3.62e-04 | 370 | 88 | 6 | 22922362 | |
| Interaction | CDC5L interactions | ORC2 TTF2 INTS6 TRIM67 ATR TRIO KALRN USO1 SYNE1 SPTBN1 COPB2 MACF1 PRKDC HUWE1 TUBGCP4 PRDM16 TBX5 | 7.03e-08 | 855 | 84 | 17 | int:CDC5L |
| Interaction | KALRN interactions | 1.50e-07 | 96 | 84 | 7 | int:KALRN | |
| Interaction | PCNT interactions | 7.42e-06 | 241 | 84 | 8 | int:PCNT | |
| Interaction | DLGAP1 interactions | 1.02e-05 | 180 | 84 | 7 | int:DLGAP1 | |
| Interaction | MECP2 interactions | MRPL4 INTS6 LIPA TRIM67 THYN1 KALRN SYNE1 SPTBN1 SPTBN2 COPB2 TNRC6B MACF1 PHF14 PRKDC ARHGAP35 LYAR CATSPERG | 1.89e-05 | 1287 | 84 | 17 | int:MECP2 |
| Interaction | TRIM65 interactions | 2.10e-05 | 80 | 84 | 5 | int:TRIM65 | |
| Interaction | AGAP2 interactions | 2.77e-05 | 210 | 84 | 7 | int:AGAP2 | |
| Interaction | TNIK interactions | 2.96e-05 | 381 | 84 | 9 | int:TNIK | |
| Interaction | DSCR9 interactions | 3.46e-05 | 147 | 84 | 6 | int:DSCR9 | |
| Interaction | SHANK3 interactions | DLGAP1 KALRN USO1 TRIM9 SYNE1 PI4KA SPTBN1 SPTBN2 MACF1 MCRS1 | 4.03e-05 | 496 | 84 | 10 | int:SHANK3 |
| Interaction | IFT57 interactions | 4.35e-05 | 93 | 84 | 5 | int:IFT57 | |
| Interaction | TCF25 interactions | 7.09e-05 | 103 | 84 | 5 | int:TCF25 | |
| Interaction | COPE interactions | 7.64e-05 | 334 | 84 | 8 | int:COPE | |
| Interaction | NRIP1 interactions | 7.78e-05 | 170 | 84 | 6 | int:NRIP1 | |
| Interaction | TRIO interactions | 9.28e-05 | 109 | 84 | 5 | int:TRIO | |
| Interaction | CEP63 interactions | 1.03e-04 | 179 | 84 | 6 | int:CEP63 | |
| Cytoband | 3q23 | 8.51e-05 | 44 | 88 | 3 | 3q23 | |
| Cytoband | 19p13.1 | 1.11e-04 | 48 | 88 | 3 | 19p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q23 | 2.49e-04 | 63 | 88 | 3 | chr3q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 8.70e-04 | 797 | 88 | 7 | chr19p13 | |
| GeneFamily | Cytochrome P450 family 4 | 2.23e-07 | 36 | 68 | 5 | 1003 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 9.73e-05 | 24 | 68 | 3 | 615 | |
| GeneFamily | EF-hand domain containing|Spectrins | 2.89e-04 | 7 | 68 | 2 | 1113 | |
| GeneFamily | ATP binding cassette subfamily A | 1.23e-03 | 14 | 68 | 2 | 805 | |
| GeneFamily | Integrator complex | 1.42e-03 | 15 | 68 | 2 | 1366 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 5.03e-07 | 20 | 86 | 4 | MM1104 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.45e-07 | 200 | 88 | 7 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.08e-06 | 169 | 88 | 6 | c8691c4f707d46b2865fe46eabe24ea4d03c7b43 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-06 | 179 | 88 | 6 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.86e-06 | 200 | 88 | 6 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.86e-06 | 200 | 88 | 6 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.86e-06 | 200 | 88 | 6 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 168 | 88 | 5 | e979a4fbeb9f21048b47d69e6da75c57650697f2 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Nfib_(Amygdala)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.13e-05 | 82 | 88 | 4 | ab081620b6113f843fede23da0a18720111ffc7c | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Nfib_(Amygdala)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.13e-05 | 82 | 88 | 4 | 1ca848a18463b1344e23e3ad1b5d01ae27c00586 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 175 | 88 | 5 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 2.83e-05 | 179 | 88 | 5 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 182 | 88 | 5 | 41f1749e2368397bca49143786da0423792f03bd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.31e-05 | 185 | 88 | 5 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.31e-05 | 185 | 88 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.31e-05 | 185 | 88 | 5 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.40e-05 | 186 | 88 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-05 | 187 | 88 | 5 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | Pericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 3.48e-05 | 187 | 88 | 5 | 35f25780d113f60bf4c13749013c09612ee4ff41 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-05 | 187 | 88 | 5 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.57e-05 | 188 | 88 | 5 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.57e-05 | 188 | 88 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 188 | 88 | 5 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.95e-05 | 192 | 88 | 5 | ed1fb700d3e8f00495727d61e164fc0b70274fd0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.95e-05 | 192 | 88 | 5 | 6779b0294bb058e748e22b795b6a381c4add37e9 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.05e-05 | 193 | 88 | 5 | e787e618f6e8a1e22be366ce606bf78831b60a90 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.05e-05 | 193 | 88 | 5 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.15e-05 | 194 | 88 | 5 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | P03-Mesenchymal|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.25e-05 | 195 | 88 | 5 | 6180309c6ae278b996fd98c57461cbc129c028ba | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.57e-05 | 198 | 88 | 5 | 58f5b5e756ab4aa7234aa8d95fba564d6e8c22d9 | |
| ToppCell | mLN-Dendritic_cell-cDC2|mLN / Region, Cell class and subclass | 4.68e-05 | 199 | 88 | 5 | cb17bccb47d04f7793709f9a4376fcc8ce95430c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.68e-05 | 199 | 88 | 5 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.68e-05 | 199 | 88 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.68e-05 | 199 | 88 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | mLN-(5)_Dendritic_cell-(50)_cDC2|mLN / shred on region, Cell_type, and subtype | 4.68e-05 | 199 | 88 | 5 | 8d1b18596a0965427abefe0be744c74e4c11d5d3 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.68e-05 | 199 | 88 | 5 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | E16.5-Mesenchymal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.68e-05 | 199 | 88 | 5 | ebd9ca151434f5ca27a82d4f1815a1ea500c1989 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 4.68e-05 | 199 | 88 | 5 | fd75dccb37d96448edf72b7d042b06833d4ead24 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | control-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.01e-04 | 146 | 88 | 4 | 69e9c1ec6eec1151290227902e75e77a4aecc8db | |
| ToppCell | COVID-19_Moderate-multiplets|COVID-19_Moderate / disease group, cell group and cell class | 2.06e-04 | 147 | 88 | 4 | baf15c773d7751bc6f64d4974a22738626f2b3ff | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.59e-04 | 156 | 88 | 4 | fc8b8aef29d6d1c0f0c1d08280d8aaff8d30535e | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 2.59e-04 | 156 | 88 | 4 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 156 | 88 | 4 | f532ef4e92ac7661b1a8a4f2e98d80ce8d4e3655 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 156 | 88 | 4 | da4f35353a84d919e683554932f110e29568df33 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 156 | 88 | 4 | f1e25ff85c5f2f8555f9fb5ae5daed7ddb418fd1 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.65e-04 | 157 | 88 | 4 | 0362c04b7b0b5017964b3a73ee678ae53e7238d7 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 157 | 88 | 4 | a426c54fd1545093d41426e9620862f71bd06f6b | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 2.78e-04 | 159 | 88 | 4 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.92e-04 | 161 | 88 | 4 | b19f82dd98a3064581793711bb70373f18abecd9 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-04 | 163 | 88 | 4 | 8d2b2119c6b3d5b677da6f377fd85146590e1246 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-04 | 163 | 88 | 4 | acfb2ece6202479e615d54fd3ecb8b4a571b5a18 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD4_TEM|Leuk-UTI / Disease, Lineage and Cell Type | 3.20e-04 | 165 | 88 | 4 | 08285c09de16ed4f488abb655a22f54bc07968ae | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.43e-04 | 168 | 88 | 4 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 3.43e-04 | 168 | 88 | 4 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-04 | 169 | 88 | 4 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-04 | 170 | 88 | 4 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-04 | 170 | 88 | 4 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-04 | 170 | 88 | 4 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.66e-04 | 171 | 88 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 3.66e-04 | 171 | 88 | 4 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-04 | 172 | 88 | 4 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-04 | 172 | 88 | 4 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-04 | 173 | 88 | 4 | 6d2ceba4f89a228600e2b40aba81bb0eb81578c0 | |
| ToppCell | severe_influenza-Neutrophil|severe_influenza / disease group, cell group and cell class (v2) | 3.83e-04 | 173 | 88 | 4 | 615e266419b9f06e964eff73cb466f05451ba0dd | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-04 | 173 | 88 | 4 | f0eb48c1283bdde313bb75f6ffc0d2626922d24b | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.83e-04 | 173 | 88 | 4 | 36a471576a9d2325066bb14c2f2cd89c67b92915 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.91e-04 | 174 | 88 | 4 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-04 | 175 | 88 | 4 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | Pericytes-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.00e-04 | 175 | 88 | 4 | ddf721023a7afc8085c5de17aa254a6575444c0f | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.00e-04 | 175 | 88 | 4 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-04 | 175 | 88 | 4 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.17e-04 | 177 | 88 | 4 | d731400997afea379f47ae8aa0f82802962b0861 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.35e-04 | 179 | 88 | 4 | b559f5a72cc9e3e35d05cb539b5c2e006e56e652 | |
| ToppCell | Control-Stromal-SMC|Control / Disease state, Lineage and Cell class | 4.35e-04 | 179 | 88 | 4 | 1378051bc62009eec2dbecf3d5d89baedbeb84eb | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Dendritic_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 180 | 88 | 4 | 5b7d2336ed09d07f6b8dd91c1fa9c5ade633c104 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.45e-04 | 180 | 88 | 4 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.54e-04 | 181 | 88 | 4 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-04 | 181 | 88 | 4 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-04 | 181 | 88 | 4 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-04 | 181 | 88 | 4 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.63e-04 | 182 | 88 | 4 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.73e-04 | 183 | 88 | 4 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.73e-04 | 183 | 88 | 4 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| Drug | paraoxon | 2.01e-07 | 164 | 86 | 8 | CID000009395 | |
| Drug | dichloran | 4.60e-07 | 41 | 86 | 5 | CID000007430 | |
| Drug | ebastine | 2.26e-06 | 25 | 86 | 4 | CID000003191 | |
| Drug | propoxyphene | 5.49e-06 | 67 | 86 | 5 | CID000010100 | |
| Drug | 18-HETE | 6.13e-06 | 10 | 86 | 3 | CID006442778 | |
| Drug | 4-bromophenol | 6.82e-06 | 70 | 86 | 5 | CID000007808 | |
| Drug | carteolol | 7.84e-06 | 72 | 86 | 5 | CID000002583 | |
| Drug | trimipramine | 1.32e-05 | 80 | 86 | 5 | CID000005584 | |
| Drug | AC1O5PIQ | 1.41e-05 | 39 | 86 | 4 | CID006438348 | |
| Drug | azo analog I | 1.45e-05 | 13 | 86 | 3 | CID006438575 | |
| Drug | diosmetin | 1.77e-05 | 85 | 86 | 5 | CID005281612 | |
| Drug | mephenytoin | 2.09e-05 | 88 | 86 | 5 | CID000004060 | |
| Drug | naphthalene-1,2-dihydrodiol | 2.51e-05 | 45 | 86 | 4 | CID000000362 | |
| Drug | tienilic acid | 2.74e-05 | 93 | 86 | 5 | CID000038409 | |
| Drug | lansoprazole | 2.74e-05 | 93 | 86 | 5 | CID000003883 | |
| Drug | 6-hydroxymelatonin | 3.83e-05 | 50 | 86 | 4 | CID000001864 | |
| Drug | AC1L1KIN | 3.88e-05 | 100 | 86 | 5 | CID000005516 | |
| Drug | Sparteinum | 4.07e-05 | 101 | 86 | 5 | CID000003966 | |
| Drug | felodipine | 4.40e-05 | 169 | 86 | 6 | CID000003333 | |
| Drug | DB75 | 4.83e-05 | 19 | 86 | 3 | CID000126437 | |
| Drug | caffeine | CYP4F8 P2RX2 SYNE1 PHF14 CYP4F2 CYP4F3 CYP4F12 GBA2 CYP4F11 PDE7B | 5.10e-05 | 562 | 86 | 10 | CID000002519 |
| Drug | chloroacetyl chloride | 5.59e-05 | 55 | 86 | 4 | CID000006577 | |
| Drug | AC1MUNZL | 6.00e-05 | 56 | 86 | 4 | CID003643892 | |
| Drug | 1,2-dihydroxynaphthalene | 6.43e-05 | 57 | 86 | 4 | CID000011318 | |
| Drug | AC1Q7AUJ | 8.22e-05 | 117 | 86 | 5 | CID000003303 | |
| Drug | 8-MOP | 8.56e-05 | 118 | 86 | 5 | CID000004114 | |
| Drug | Cromolyn disodium salt [15826-37-6]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.00e-04 | 196 | 86 | 6 | 3475_UP | |
| Drug | Josamycin [16846-24-5]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.00e-04 | 196 | 86 | 6 | 5692_UP | |
| Drug | Clidinium bromide [3485-62-9]; Up 200; 9.2uM; HL60; HT_HG-U133A | 1.00e-04 | 196 | 86 | 6 | 2734_UP | |
| Drug | Amrinone [60719-84-8]; Up 200; 21.4uM; PC3; HT_HG-U133A | 1.03e-04 | 197 | 86 | 6 | 4488_UP | |
| Drug | Cefotetan [69712-56-7]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.03e-04 | 197 | 86 | 6 | 4116_UP | |
| Drug | Nifurtimox [23256-30-6]; Up 200; 14uM; PC3; HT_HG-U133A | 1.09e-04 | 199 | 86 | 6 | 6608_UP | |
| Drug | hexobarbital | 1.21e-04 | 127 | 86 | 5 | CID000003608 | |
| Drug | lithium dimer | 1.27e-04 | 26 | 86 | 3 | CID000139759 | |
| Drug | chloral hydrate | 1.30e-04 | 129 | 86 | 5 | CID000002707 | |
| Drug | diclofenac | 1.42e-04 | 209 | 86 | 6 | CID000003032 | |
| Drug | C14845 | 1.43e-04 | 27 | 86 | 3 | CID011954064 | |
| Drug | BP-9,10-oxide | 1.43e-04 | 27 | 86 | 3 | CID000037456 | |
| Drug | Brn 4136738 | 1.43e-04 | 27 | 86 | 3 | CID000050331 | |
| Drug | 1,2-dibromoethane | 1.52e-04 | 71 | 86 | 4 | CID000007839 | |
| Drug | 9-OH-BaP-4,5-oxide | 1.59e-04 | 28 | 86 | 3 | CID000115064 | |
| Drug | aminoglutethimide | 1.73e-04 | 137 | 86 | 5 | CID000002145 | |
| Drug | 11-H-14,15-EETA | 1.96e-04 | 30 | 86 | 3 | CID011954058 | |
| Drug | 19-hydroxytestosterone | 1.96e-04 | 30 | 86 | 3 | CID000150968 | |
| Drug | 1wbv | 1.96e-04 | 30 | 86 | 3 | CID005326870 | |
| Disease | acylphosphatase-2 measurement | 4.90e-05 | 4 | 85 | 2 | EFO_0801344 | |
| Disease | autosomal recessive congenital ichthyosis 1 (is_implicated_in) | 4.90e-05 | 4 | 85 | 2 | DOID:0060656 (is_implicated_in) | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 4.90e-05 | 4 | 85 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | Opitz GBBB syndrome (implicated_via_orthology) | 1.22e-04 | 6 | 85 | 2 | DOID:0080697 (implicated_via_orthology) | |
| Disease | interferon-induced protein with tetratricopeptide repeats 3 measurement | 2.27e-04 | 8 | 85 | 2 | EFO_0801710 | |
| Disease | sialic acid-binding Ig-like lectin 12 measurement | 2.27e-04 | 8 | 85 | 2 | EFO_0802066 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 2.91e-04 | 9 | 85 | 2 | EFO_0800562 | |
| Disease | PR interval | 5.73e-04 | 495 | 85 | 7 | EFO_0004462 | |
| Disease | Short Rib-Polydactyly Syndrome | 6.27e-04 | 13 | 85 | 2 | C0036996 | |
| Disease | Saldino-Noonan Syndrome | 7.30e-04 | 14 | 85 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 7.30e-04 | 14 | 85 | 2 | C0024507 | |
| Disease | cortex volume change measurement | 8.40e-04 | 15 | 85 | 2 | EFO_0021500 | |
| Disease | Headache | 8.47e-04 | 64 | 85 | 3 | HP_0002315 | |
| Disease | Rolandic epilepsy | 9.59e-04 | 16 | 85 | 2 | Orphanet_1945 | |
| Disease | monocyte count | TTF2 NLRP12 KALRN PI4KA IFT81 SPTBN1 SPTBN2 MARCHF7 PRKDC S1PR3 CNN2 | 1.41e-03 | 1320 | 85 | 11 | EFO_0005091 |
| Disease | stearoylcarnitine measurement | 2.17e-03 | 24 | 85 | 2 | EFO_0021045 | |
| Disease | Neurodevelopmental Disorders | 2.48e-03 | 93 | 85 | 3 | C1535926 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WQVHISLKLMQQSSL | 556 | Q6ZRH7 | |
| QNHTSEIFKWKSMIS | 96 | Q96M60 | |
| AQIIQRAWLSHTNKM | 46 | Q96LI9 | |
| WAKHSEVQQANLKAM | 316 | P35606 | |
| MASLFHQLQILVWKN | 1 | Q86UK0 | |
| MWLQQQLVHAHKKAD | 1331 | Q9BXX3 | |
| LALHCQQFWAMFLKK | 901 | Q99758 | |
| KNQFMQRLHNYWLLK | 496 | Q9ULD4 | |
| LHQLKANNWKQMDPL | 891 | O14490 | |
| FQQKWIFLNKVLHEM | 1261 | Q96M86 | |
| WKENHATFMSELKNL | 66 | Q5JSJ4 | |
| WKENHATFMNELKNL | 66 | Q9UL03 | |
| QQHNMSWIEVQFLKK | 446 | Q9Y4X5 | |
| SMNSQKRHLTWTLKL | 291 | Q14667 | |
| SWKRYPASMKQLQQH | 446 | Q86VH4 | |
| QLSEFWKSHNLDMIQ | 41 | P14091 | |
| VLQMHSAQAWKKALA | 226 | Q96R30 | |
| IQWGMLNFLSLKNMH | 301 | Q8NH59 | |
| NMLGHLAHNKAQWKS | 401 | Q9NP56 | |
| KMFDWISHNKELFLQ | 321 | O60229 | |
| QLLAHQFIWNMKTNI | 1681 | P42356 | |
| ANMKLESRILKWHQQ | 96 | Q9C075 | |
| WALQMQRKHLKSNQT | 496 | Q9UGJ1 | |
| LLHKMESKSSNQLSW | 3271 | Q7Z6Z7 | |
| EKSQNWSSQKMDHIL | 306 | O94880 | |
| QKVMALWHQLHVNTK | 941 | Q9UPN3 | |
| AHMKSSAWVNKIQVL | 31 | Q13093 | |
| NWNKFLMAIKTSHSP | 1711 | Q9UG01 | |
| WILLTFMNKNKVYSH | 361 | Q9UBL9 | |
| YWKILAAQHKCKMNN | 471 | Q9ULW2 | |
| IKHVDMNQKSILWSA | 451 | Q13535 | |
| HLKKRVETAQNHQWM | 191 | Q8WYA0 | |
| WHKKMDFSQNVNVSS | 56 | D3W0D1 | |
| TWNQKETYLHIMKNE | 201 | Q9BXJ1 | |
| RHWQQLMQATQVKFK | 1361 | Q9UFH2 | |
| MQLALQQQQHKKASW | 886 | Q9HCG7 | |
| IFNKSVNIMHDKWQR | 166 | Q9HBI6 | |
| IFSKSANIMHAKWQR | 166 | P98187 | |
| IFNKSANIMLDKWQH | 166 | Q9HCS2 | |
| IFNESVNIMHAKWQL | 166 | P78329 | |
| RTAKALQAHWQLMKQ | 246 | Q96EZ8 | |
| LQYVHQDCMKKWLQA | 576 | Q9H992 | |
| NWMKNSLKVHNESIL | 116 | Q9NX58 | |
| LVKSWNNSLLMKIFH | 126 | Q6ZS86 | |
| NLSSLFDSQWHKIMI | 171 | P20849 | |
| IFNESVNIMHAKWQL | 166 | Q08477 | |
| LIAIWKNNKFHNRMY | 61 | Q99500 | |
| KNMKHLWFFLLLVAA | 6 | P06331 | |
| NQQYEKLFHKWMLQL | 291 | Q13416 | |
| KLFHKWMLQLHLGFN | 296 | Q13416 | |
| TQHLDIGLKQKQWLM | 106 | P29084 | |
| NVTWKIKLRNAMHLS | 161 | P59543 | |
| GWSAQKVTNLHLMLQ | 271 | O60763 | |
| SHMQKVALFKLQSYW | 176 | A5PLK6 | |
| VENHKKQMLSNQASW | 81 | Q12981 | |
| LHQVAMWQKNFKRIS | 96 | Q9BYD3 | |
| LQIIDKRMSHQKTFW | 731 | Q4G0N8 | |
| WLSNTNKMSKELHRL | 6776 | Q8NF91 | |
| AHWMRQLVSFQKLKL | 146 | Q99593 | |
| WLNGSSLLQHMKFNN | 301 | Q96ME1 | |
| KAFNWKSNLIRHQMS | 316 | Q9HAZ2 | |
| WLGLQNMHLLTLKQK | 111 | P55083 | |
| AQTSKHLFWANKLIQ | 151 | Q96LK8 | |
| FVKKHNLMSLNSINW | 211 | Q86YJ6 | |
| KQVLHNKLGWVLSMS | 306 | Q6PJ21 | |
| KNHNENWLSVSRKMQ | 286 | Q9NRY4 | |
| ARNLHSKWLKHQAFM | 1306 | Q01082 | |
| NKIWTLKFSHNISNK | 61 | Q8WTS1 | |
| WYQHLQINKKMTNEV | 306 | Q8IV77 | |
| NWHQLENLSNFIKAM | 81 | Q99439 | |
| QKLNTWNGDLAKMTH | 11 | Q8IUQ0 | |
| GAMWKQHKAQLSQAL | 341 | Q6ZTA4 | |
| FWNSSLLTQKQEVHM | 196 | Q86XN6 | |
| NLHTKWQKHQAFMAE | 1311 | O15020 | |
| WQKHQAFMAELAANK | 1316 | O15020 | |
| QTFKWHSSLANHKNM | 471 | A6NP11 | |
| PLVMQLIHWFTNNKK | 986 | P78527 | |
| WQQLVKHRMFFSKQD | 231 | O43543 | |
| LGAMWKLHKSQLSQA | 266 | Q9C026 | |
| TKNCLKNLSSHWLMK | 46 | Q9P016 | |
| QQMLALSEQKRIKHW | 206 | P51815 | |
| WHQKNAMNLNLQKAL | 251 | O43247 | |
| DFWMSSNLHQLQKLD | 126 | Q6P9A1 | |
| SFTEKWALNNHMKLH | 1636 | Q9C0G0 | |
| NQWNKAVELAKNHSM | 896 | Q9P2L0 | |
| ISSMNISIQNTWKHL | 436 | Q8NA31 | |
| NALWKAMEKSSLTQH | 161 | Q9NYB0 | |
| KMFDWITHNKGLFLN | 351 | O75962 | |
| LSNKMWKNHISSRNT | 1581 | Q9UPQ9 | |
| SQWTNMLKVVALHLK | 1016 | Q9UNY4 | |
| QNMLHWSQAVKFQKF | 291 | P38571 | |
| HIKMDLLQWIQSKAQ | 586 | P59046 |